Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement
- Univ. of Washington, Seattle, WA (United States)
- Vir Biotechnology, San Francisco, CA (United States)
- Univ. of Cambridge (United Kingdom)
- Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States)
- Vir Biotechnology, San Francisco, CA (United States); Washington Univ., St. Louis, MO (United States). School of Medicine; Univ. of Texas Southwestern Medical Center, Dallas, TX (United States)
- Humabs Biomed SA, Bellinzona, (Switzerland)
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant of concern evades antibody-mediated immunity that comes from vaccination or infection with earlier variants due to accumulation of numerous spike mutations. To understand the Omicron antigenic shift, we determined cryo–electron microscopy and x-ray crystal structures of the spike protein and the receptor-binding domain bound to the broadly neutralizing sarbecovirus monoclonal antibody (mAb) S309 (the parent mAb of sotrovimab) and to the human ACE2 receptor. We provide a blueprint for understanding the marked reduction of binding of other therapeutic mAbs that leads to dampened neutralizing activity. Remodeling of interactions between the Omicron receptor-binding domain and human ACE2 likely explains the enhanced affinity for the host receptor relative to the ancestral virus.
- Research Organization:
- Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)
- Sponsoring Organization:
- Burroughs Wellcome Fund; Fast Grants; National Institute of General Medical Sciences; National Institutes of Health (NIH); USDOE Office of Science (SC); University of Washington Arnold and Mabel Beckman Cryo-EM Center
- Grant/Contract Number:
- AC02-05CH11231
- OSTI ID:
- 1891296
- Journal Information:
- Science, Journal Name: Science Journal Issue: 6583 Vol. 375; ISSN 0036-8075
- Publisher:
- AAASCopyright Statement
- Country of Publication:
- United States
- Language:
- English
SARS-CoV-2 spike N-terminal domain modulates TMPRSS2-dependent viral entry and fusogenicity.
|
journalarticle | January 2022 |
Similar Records
Distinct Conformations of SARS-CoV-2 Omicron Spike Protein and Its Interaction with ACE2 and Antibody
SARS-CoV-2 spike protein variant binding affinity to an angiotensin-converting enzyme 2 fusion glycoproteins
Journal Article
·
Mon Feb 13 19:00:00 EST 2023
· International Journal of Molecular Sciences (Online)
·
OSTI ID:2471224
SARS-CoV-2 spike protein variant binding affinity to an angiotensin-converting enzyme 2 fusion glycoproteins
Journal Article
·
Mon Dec 05 19:00:00 EST 2022
· PLoS ONE
·
OSTI ID:2425791